BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 185 filers reported holding BLUEPRINT MEDICINES CORP in Q2 2018. The put-call ratio across all filers is 0.43 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $7,000 | -66.7% | 85 | -70.9% | 0.00% | – |
| Q3 2019 | $21,000 | -25.0% | 292 | +1.0% | 0.00% | – |
| Q2 2019 | $28,000 | -6.7% | 289 | -23.7% | 0.00% | – |
| Q1 2019 | $30,000 | +200.0% | 379 | +101.6% | 0.00% | – |
| Q4 2018 | $10,000 | -9.1% | 188 | +27.9% | 0.00% | – |
| Q3 2018 | $11,000 | +1000.0% | 147 | +950.0% | 0.00% | – |
| Q2 2018 | $1,000 | -88.9% | 14 | -86.0% | 0.00% | – |
| Q1 2018 | $9,000 | -78.0% | 100 | -81.8% | 0.00% | -100.0% |
| Q4 2017 | $41,000 | +17.1% | 550 | +10.0% | 0.00% | 0.0% |
| Q3 2017 | $35,000 | – | 500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 716,539 | $36,192,000 | 12.35% |
| CADIAN CAPITAL MANAGEMENT, LP | 2,020,629 | $102,062,000 | 6.89% |
| Casdin Capital, LLC | 1,150,000 | $58,087,000 | 4.91% |
| DAFNA Capital Management LLC | 261,280 | $13,197,000 | 3.60% |
| Nextech Invest Ltd. | 188,228 | $9,507,000 | 3.21% |
| Eagle Health Investments LP | 170,551 | $8,615,000 | 2.01% |
| Boxer Capital, LLC | 507,374 | $25,627,000 | 1.62% |
| Rock Springs Capital Management LP | 979,174 | $49,458,000 | 1.44% |
| EFG Asset Management (North America) Corp. | 130,454 | $6,589,000 | 1.39% |
| Integral Health Asset Management, LLC | 130,000 | $6,566,000 | 1.35% |